The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
Open accessAbstract
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic provide recommendations for genetic testing and counseling for hereditary cancer syndromes, and risk management recommendations for patients who are diagnosed with syndromes associated with an increased risk of these cancers. The NCCN panel meets at least annually to review comments, examine relevant new data, and reevaluate and update recommendations. These NCCN Guidelines Insights summarize the panel’s discussion and most recent recommendations regarding criteria for high-penetrance genes associated with breast and ovarian cancer beyond BRCA1/2, pancreas screening and genes associated with pancreatic cancer, genetic testing for the purpose of systemic therapy decision-making, and testing for people with Ashkenazi Jewish ancestry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Robson, M., Im, S.-A., Senkus, E., Xu, B., Domchek, S. M., Masuda, N., Delaloge, S., Li, W., Tung, N., Armstrong, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706450 · Cited by 3,294
Self-citationACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J.-O., Hochhauser, D., Arnold, D., Oh, D.-Y., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903387 · Cited by 2,302
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Litton, J. K., Rugo, H. S., Ettl, J., Hurvitz, S. A., Gonçalves, A., Lee, K.-H., Fehrenbacher, L., Yerushalmi, R., Mina, L. A., Martin, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802905 · Cited by 2,175
Self-citationOlaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
Kaufman, B., Shapira-Frommer, R., Schmutzler, R. K., Audeh, M. W., Friedlander, M., Balmaña, J., Mitchell, G., Fried, G., Stemmer, S. M., Hubert, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2728 · Cited by 1,671
Self-citationSyngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Swisher, E. M., Lin, K. K., Oza, A. M., Scott, C. L., Giordano, H., Sun, J., Konecny, G. E., Coleman, R. L., Tinker, A. V., O'Malley, D. M., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30559-9 · Cited by 1,196
Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 934
Self-citationExomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826
Self-citationCancers with increasing incidence trends in the United States: 1999 through 2008
Simard, E. P., Ward, E. M., Siegel, R., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20141 · Cited by 724
Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds
Klein, A. P., Brune, K. A., Petersen, G. M., Goggins, M., Tersmette, A. C., Offerhaus, G. J. A., Griffin, C., Cameron, J. L., Yeo, C. J., Kern, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3823 · Cited by 678
Self-citationSpectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
Walsh, T., Casadei, S., Coats, K. H., Swisher, E., Stray, S. M., Higgins, J., Roach, K. C., Mandell, J., Lee, M. K., Ciernikova, S., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1379 · Cited by 666
Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659
Self-citationFrequent detection of pancreatic lesions in asymptomatic high-risk individuals
Canto, M. I., Hruban, R. H., Fishman, E. K., Kamel, I. R., Schulick, R., Zhang, Z., Topazian, M., Takahashi, N., Fletcher, J., Petersen, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.005 · Cited by 648
Self-citationMateo, J., Porta, N., Bianchini, D., McGovern, U., Elliott, T., Jones, R., Syndikus, I., Ralph, C., Jain, S., Varughese, M., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30684-9 · Cited by 634
Hu, C., Hart, S. N., Polley, E. C., Gnanaolivu, R., Shimelis, H., Lee, K. Y., Lilyquist, J., Na, J., Moore, R., Antwi, S. O., et al. (2018) · JAMA · doi:10.1001/jama.2018.6228 · Cited by 577
Moore, K. N., Secord, A. A., Geller, M. A., Miller, D. S., Cloven, N., Fleming, G. F., Wahner Hendrickson, A. E., Azodi, M., DiSilvestro, P., Oza, A. M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30029-4 · Cited by 533
ATM Mutations in Patients with Hereditary Pancreatic Cancer
Roberts, N. J., Jiao, Y., Yu, J., Kopelovich, L., Petersen, G. M., Bondy, M. L., Gallinger, S., Schwartz, A. G., Syngal, S., Cote, M. L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0194 · Cited by 491
Self-citationWalsh, T., Lee, M. K., Casadei, S., Thornton, A. M., Stray, S. M., Pennil, C., Nord, A. S., Mandell, J. B., Swisher, E. M., & King, M.-C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007983107 · Cited by 487
Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S., McGuire, V., Ladabaum, U., Kobayashi, Y., Lincoln, S. E., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6607 · Cited by 485
Self-citationDeleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma
Shindo, K., Yu, J., Suenaga, M., Fesharakizadeh, S., Cho, C., Macgregor-Das, A., Siddiqui, A., Witmer, P. D., Tamura, K., Song, T. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.3502 · Cited by 458
Self-citationOlaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
(2017) · New England Journal of Medicine · doi:10.1056/nejmx170012 · Cited by 431
Tung, N., Battelli, C., Allen, B., Kaldate, R., Bhatnagar, S., Bowles, K., Timms, K., Garber, J. E., Herold, C., Ellisen, L., et al. (2015) · Cancer · doi:10.1002/cncr.29010 · Cited by 430
Self-citationRobson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0660 · Cited by 421
Self-citationCanto, M. I., Almario, J. A., Schulick, R. D., Yeo, C. J., Klein, A., Blackford, A., Shin, E. J., Sanyal, A., Yenokyan, G., Lennon, A. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.035 · Cited by 414
Self-citationGermline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma
Holter, S., Borgida, A., Dodd, A., Grant, R., Semotiuk, K., Hedley, D., Dhani, N., Narod, S., Akbari, M., Moore, M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7401 · Cited by 398
Clarke, N., Wiechno, P., Alekseev, B., Sala, N., Jones, R., Kocak, I., Chiuri, V. E., Jassem, J., Fléchon, A., Redfern, C., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30365-6 · Cited by 396
Vasen, H., Ibrahim, I., Ponce, C. G., Slater, E. P., Matthäi, E., Carrato, A., Earl, J., Robbers, K., van Mil, A. M., Potjer, T., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0730 · Cited by 344
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
Gabai-Kapara, E., Lahad, A., Kaufman, B., Friedman, E., Segev, S., Renbaum, P., Beeri, R., Gal, M., Grinshpun-Cohen, J., Djemal, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415979111 · Cited by 342
Projecting the Supply and Demand for Certified Genetic Counselors: a Workforce Study
Hoskovec, J. M., Bennett, R. L., Carey, M. E., DaVanzo, J., Dougherty, M., Hahn, S. E., LeRoy, B. S., O'Neal, S., Richardson, J. G., & Wicklund, C. A. L. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0158-8 · Cited by 340
LaDuca, H., Stuenkel, A. J., Dolinsky, J. S., Keiles, S., Tandy, S., Pesaran, T., Chen, E., Gau, C.-L., Palmaer, E., Shoaepour, K., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.40 · Cited by 332
Counselling framework for moderate-penetrance cancer-susceptibility mutations
Tung, N., Domchek, S. M., Stadler, Z., Nathanson, K. L., Couch, F., Garber, J. E., Offit, K., & Robson, M. E. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.90 · Cited by 314
Self-citationPrevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer
Grant, R. C., Selander, I., Connor, A. A., Selvarajah, S., Borgida, A., Briollais, L., Petersen, G. M., Lerner-Ellis, J., Holter, S., & Gallinger, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.042 · Cited by 299
Lancaster, J. M., Powell, C. B., Chen, L.-M., & Richardson, D. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.09.009 · Cited by 298
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study
Zhen, D. B., Rabe, K. G., Gallinger, S., Syngal, S., Schwartz, A. G., Goggins, M. G., Hruban, R. H., Cote, M. L., McWilliams, R. R., Roberts, N. J., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.153 · Cited by 295
Self-citationPALB2 mutations in European familial pancreatic cancer families
Slater, E., Langer, P., Niemczyk, E., Strauch, K., Butler, J., Habbe, N., Neoptolemos, J., Greenhalf, W., & Bartsch, D. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01425.x · Cited by 278
The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Brune, K., de Andrade, M., Goggins, M., Rothenmund, H., Gallinger, S., Klein, A., Petersen, G. M., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0783 · Cited by 275
Self-citationTandy-Connor, S., Guiltinan, J., Krempely, K., LaDuca, H., Reineke, P., Gutierrez, S., Gray, P., & Tippin Davis, B. (2018) · Genetics in Medicine · doi:10.1038/gim.2018.38 · Cited by 273
Trepanier, A., Ahrens, M., McKinnon, W., Peters, J., Stopfer, J., Grumet, S. C., Manley, S., Culver, J. O., Acton, R., Larsen‐Haidle, J., et al. (2004) · Journal of Genetic Counseling · doi:10.1023/b:jogc.0000018821.48330.77 · Cited by 264
Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
Casadei, S., Norquist, B. M., Walsh, T., Stray, S., Mandell, J. B., Lee, M. K., Stamatoyannopoulos, J. A., & King, M.-C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3958 · Cited by 240
Self-citationEccles, D. M., Mitchell, G., Monteiro, A. N. A., Schmutzler, R., Couch, F. J., Spurdle, A. B., Gómez-García, E. B., Driessen, R., Lindor, N. M., Blok, M. J., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv278 · Cited by 226
Self-citationProspective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
Lowery, M. A., Wong, W., Jordan, E. J., Lee, J. W., Kemel, Y., Vijai, J., Mandelker, D., Zehir, A., Capanu, M., Salo-Mullen, E., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy024 · Cited by 224
Self-citationYurgelun, M. B., Chittenden, A. B., Morales-Oyarvide, V., Rubinson, D. A., Dunne, R. F., Kozak, M. M., Qian, Z. R., Welch, M. W., Brais, L. K., Da Silva, A., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0009-5 · Cited by 217
Self-citationBRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma
Ferrone, C. R., Levine, D. A., Tang, L. H., Allen, P. J., Jarnagin, W., Brennan, M. F., Offit, K., & Robson, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5546 · Cited by 206
Self-citationThe Genetic Information Nondiscrimination Act of 2008
Donald, C. G., & Sanders, A. K. (2008) · Journal of Diversity Management (JDM) · doi:10.19030/jdm.v3i4.5000 · Cited by 204
Shared Genetic Susceptibility to Breast Cancer, Brain Tumors, and Fanconi Anemia
Offit, K., Levran, O., Mullaney, B., Mah, K., Nafa, K., Batish, S. D., Diotti, R., Schneider, H., Deffenbaugh, A., Scholl, T., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg072 · Cited by 201
Self-citationIdentification of germline genetic mutations in patients with pancreatic cancer
Salo‐Mullen, E. E., O'Reilly, E. M., Kelsen, D. P., Ashraf, A. M., Lowery, M. A., Yu, K. H., Reidy, D. L., Epstein, A. S., Lincoln, A., Saldia, A., et al. (2015) · Cancer · doi:10.1002/cncr.29664 · Cited by 198
Self-citationBerliner, J. L., & Fay, A. M. (2007) · Journal of Genetic Counseling · doi:10.1007/s10897-007-9090-7 · Cited by 193
Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer
Kurian, A. W., Ward, K. C., Hamilton, A. S., Deapen, D. M., Abrahamse, P., Bondarenko, I., Li, Y., Hawley, S. T., Morrow, M., Jagsi, R., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0644 · Cited by 193
Self-citationTran, S. D., Pillemer, S. R., Dutra, A., Barrett, A. J., Brownstein, M. J., Key, S., Pak, E., Leakan, R. A., Kingman, A., Yamada, K. M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12894-2 · Cited by 184
Manchanda, R., Patel, S., Gordeev, V. S., Antoniou, A. C., Smith, S., Lee, A., Hopper, J. L., MacInnis, R. J., Turnbull, C., Ramus, S. J., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx265 · Cited by 179
Balmaña, J., Digiovanni, L., Gaddam, P., Walsh, M. F., Joseph, V., Stadler, Z. K., Nathanson, K. L., Garber, J. E., Couch, F. J., Offit, K., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.4316 · Cited by 174
Self-citationGenetic Information Nondiscrimination Act
Funke, R. D., Dillard, B., Potthast, A., Boxall, S. F., Carr, E., Carr, S., Diaz-Sprague, R., Elliott, D. L., England, R., & Price, C. (2008) · Ethics & Behavior · Cited by 160
Petersen, G. M. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.09.002 · Cited by 157
Berliner, J. L., Fay, A. M., Cummings, S. A., Burnett, B. B., & Tillmanns, T. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9547-1 · Cited by 155
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
Kaufman, B., Shapira-Frommer, R., Schmutzler, R. K., et al. (2015) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 154
Brune, K. A., & Klein, A. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-69252-4_5 · Cited by 150
Gene Panel Testing for Inherited Cancer Risk
Hall, M. J., Forman, A. D., Pilarski, R., Wiesner, G. L., & Giri, V. N. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0128 · Cited by 149
Self-citationChaffee, K. G., Oberg, A. L., McWilliams, R. R., Majithia, N., Allen, B. A., Kidd, J., Singh, N., Hartman, A.-R., Wenstrup, R. J., & Petersen, G. M. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.85 · Cited by 144
Prevalence of pathogenic mutations in cancer predisposition genes among pancreatic cancer patients
Hu, C., Hart, S. N., Bamlet, W. R., Moore, R. M., Nandakumar, K., Eckloff, B. W., Lee, Y. K., Petersen, G. M., McWilliams, R. R., & Couch, F. J. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0455 · Cited by 137
Manchanda, R., Loggenberg, K., Sanderson, S., Burnell, M., Wardle, J., Gessler, S., Side, L., Balogun, N., Desai, R., Kumar, A., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju379 · Cited by 135
Somatic TP53 variants frequently confound germ-line testing results
Weitzel, J. N., Chao, E., Nehoray, B., Tongeren, L. R. V., LaDuca, H., Blazer, K. R., Slavin, T. P., Pesaran, T. F., Rybak, C., Solomon, I. B., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.196 · Cited by 134
Self-citationContribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome
Renaux‐Petel, M., Charbonnier, F., Théry, J., Fermey, P., Lienard, G., Bou, J., Coutant, S., Vézain, M., Kasper, E., Fourneaux, S., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104976 · Cited by 131
Kapoor, N. S., Curcio, L. D., Blakemore, C. A., Bremner, A. K., McFarland, R. E., West, J. G., & Banks, K. C. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4754-2 · Cited by 111
An overview of hereditary pancreatitis
Rebours, V., Lévy, P., & Ruszniewski, P. B. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.08.003 · Cited by 110
Abe, T., Blackford, A. L., Tamura, K., Ford, M., McCormick, P., Chuidian, M., Almario, J. A., Borges, M., Lennon, A. M., Shin, E. J., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01512 · Cited by 102
Self-citationPancreatic cancer risk in hereditary pancreatitis
Weiß, F. U. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00070 · Cited by 90
Genetic Testing for Cancer Susceptibility
Calzone, K. A., & Soballe, P. W. (2008) · Surgical Clinics of North America · doi:10.1016/j.suc.2008.05.003 · Cited by 85
Lucas, A. L., Shakya, R., Lipsyc, M. D., Mitchel, E. B., Kumar, S., Hwang, C., Deng, L., DeVoe, C., Chabot, J. A., Szabolcs, M. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3020 · Cited by 80
Translating Genomics in Cancer Care
Bombard, Y., Bach, P. B., & Offit, K. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0158 · Cited by 78
Self-citationMauer, C. B., Pirzadeh-Miller, S. M., Robinson, L. D., & Euhus, D. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.160 · Cited by 74
Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer
Katz, S. J., Ward, K. C., Hamilton, A. S., McLeod, M. C., Wallner, L. P., Morrow, M., Jagsi, R., Hawley, S. T., & Kurian, A. W. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.2369 · Cited by 73
Self-citationClinical and pathologic features of familial pancreatic cancer
Humphris, J. L., Johns, A. L., Simpson, S. H., Cowley, M. J., Pajic, M., Chang, D. K.-F., Nagrial, A. M., Chin, V. T., Chantrill, L. A., Pinese, M., et al. (2014) · Cancer · doi:10.1002/cncr.28863 · Cited by 69
Vadaparampil, S. T., Scherr, C. L., Cragun, D. L., Malo, T. L., & Pal, T. (2014) · Clinical Genetics · doi:10.1111/cge.12405 · Cited by 68
Self-citationThird party interpretation of raw genetic data: an ethical exploration
Badalato, L., Kalokairinou, L., & Borry, P. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.126 · Cited by 61
Next-Generation Sequencing for Inherited Breast Cancer Risk: Counseling through the Complexity
Rainville, I. R., & Rana, H. Q. (2014) · Current Oncology Reports · doi:10.1007/s11912-013-0371-z · Cited by 61
The Role of Genetics in Pancreatitis
Hasan, A., Moscoso, D. I., & Kastrinos, F. (2018) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2018.06.001 · Cited by 59
Differences in BRCA counseling and testing practices based on ordering provider type
Cragun, D. L., Camperlengo, L. P., Robinson, E. K., Caldwell, M., Kim, J., Phelan, C., Monteiro, Á. N. A., Vadaparampil, S. T., Sellers, T. A., & Pal, T. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.75 · Cited by 58
Self-citationVail, P. J., Morris, B., van Kan, A., Burdett, B. C., Moyes, K., Theisen, A. P., Kerr, I. D., WENSTRUP, R. J., & Eggington, J. M. (2015) · Journal of Community Genetics · doi:10.1007/s12687-015-0220-x · Cited by 57
Consistency ofBRCA1andBRCA2Variant Classifications Among Clinical Diagnostic Laboratories
Lincoln, S. E., Yang, S., Cline, M., Kobayashi, Y., Zhang, C., Topper, S., Haussler, D. H., Paten, B., & Nussbaum, R. L. (2017) · JCO Precision Oncology · doi:10.1200/po.16.00020 · Cited by 55
Hong, Y. C., Liu, H. M., Chen, P., Chen, Y. J., Lyou, J., Hu, H., Yi, M. F., Js, L., & Tzeng, C. H. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705823 · Cited by 43
Lieberman, S., Tomer, A., Ben-Chetrit, A., Olsha, O., Strano, S., Beeri, R., Koka, S., Fridman, H., Djemal, K., Glick, I., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0734-4 · Cited by 38
Routine use of gene panel testing in hereditary breast cancer should be performed with caution
van Marcke, C., Leener, A. D., Berlière, M., Vikkula, M., & Duhoux, F. P. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.10.008 · Cited by 24
Cited by
Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment
Kurnit, K. C., Fleming, G. F., & Lengyel, E. (2021) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004173 · Cited by 322
Samadder, N. J., Riegert-Johnson, D., Boardman, L., Rhodes, D., Wick, M., Okuno, S., Kunze, K. L., Golafshar, M., Uson, P. L. S., Mountjoy, L., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.6252 · Cited by 304
Self-citationSessa, C., Balmaña, J., Bober, S. L., Cardoso, M. J., Colombo, N., Curigliano, G., Domchek, S. M., Evans, D. G., Fischerova, D., Harbeck, N., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2022.10.004 · Cited by 295
Self-citationGermline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
Bedrosian, I., Somerfield, M. R., Achatz, M. I., Boughey, J. C., Curigliano, G., Friedman, S., Kohlmann, W. K., Kurian, A. W., Laronga, C., Lynce, F., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02225 · Cited by 216
“Women who met NCCN criteria for genetic testing were more likely to carry a pathogenic variant in the nine genes (9.0”
BackgroundInfluentialSelf-citationUnique roles of rare variants in the genetics of complex diseases in humans
Momozawa, Y., & Mizukami, K. (2021) · Journal of Human Genetics · doi:10.1038/s10038-020-00845-2 · Cited by 161
Metadata
- Authors
- Daly, M. B., Pilarski, R., Yurgelun, M. B., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Garber, J. E., Goggins, M., Hutton, M. L., Khan, S., Klein, C., Kohlmann, W., Kurian, A. W., Laronga, C., Litton, J. K., Mak, J. S., Menendez, C. S., Merajver, S. D., Norquist, B. S., Offit, K., Pal, T., Pederson, H. J., Reiser, G., Shannon, K. M., Visvanathan, K., Weitzel, J. N., Wick, M. J., Wisinski, K. B., Dwyer, M. A., & Darlow, S. D.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2020-04
- Volume
- 18
- Issue
- 4
- Pages
- 380-391
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W3015141169
- Cited by
- 505
- References
- 85
- FWCI
- 50.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.